Evidence map›Paper›PMID 28542170›Full record

ArticlePLoS genetics2017

Human mutations in integrator complex subunits link transcriptome integrity to brain development.

Renske Oegema, David Baillat, Rachel Schot, Leontine M van Unen, Alice Brooks, Sima Kheradmand Kia, A Jeannette M Hoogeboom, Zheng Xia, Wei Li, Matteo Cesaroni and 11 more

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in PLoS genetics, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 73 papers.

0numbers the graph read from it
0cells of the map it votes in
73citing papers in PubMed
4.5field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

73 citing papers in PubMed, 112 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Novel BiallelicGenes · 2025
    Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Review
  20. Article

13 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

21 authors at 4 institutions in 2 countries.

Renske OegemaDepartment of Clinical Genetics, Erasmus MC University Medical Center, Rotterdam, The Netherlands.
David BaillatDepartment of Biochemistry & Molecular Biology, University of Texas Medical Branch, Galveston TX, United States of America.ORCID http://orcid.org/0000-0001-9794-374X
Rachel SchotDepartment of Clinical Genetics, Erasmus MC University Medical Center, Rotterdam, The Netherlands.ORCID http://orcid.org/0000-0001-9578-4095
Leontine M van UnenDepartment of Clinical Genetics, Erasmus MC University Medical Center, Rotterdam, The Netherlands.ORCID http://orcid.org/0000-0003-1174-9140
Alice BrooksDepartment of Clinical Genetics, Erasmus MC University Medical Center, Rotterdam, The Netherlands.
Sima Kheradmand KiaDepartment of Clinical Genetics, Erasmus MC University Medical Center, Rotterdam, The Netherlands.
A Jeannette M HoogeboomDepartment of Clinical Genetics, Erasmus MC University Medical Center, Rotterdam, The Netherlands.
Zheng XiaDivision of Biostatistics, Dan L Duncan Cancer Center, Baylor College of Medicine, Houston, TX, United States of America.ORCID http://orcid.org/0000-0003-3364-8324
Wei LiDivision of Biostatistics, Dan L Duncan Cancer Center, Baylor College of Medicine, Houston, TX, United States of America.
Matteo CesaroniThe Fels Institute, Temple University School of Medicine, Philadelphia, PA, United States of America.ORCID http://orcid.org/0000-0002-6377-8157
Maarten H LequinDepartment of Pediatric Radiology, Erasmus MC- Sophia, University Medical Center Rotterdam, The Netherlands.
Marjon van SlegtenhorstDepartment of Clinical Genetics, Erasmus MC University Medical Center, Rotterdam, The Netherlands.
William B DobynsCenter for Integrative Brain Research, Seattle Children's Research Institute, Seattle, Washington, United States of America.
Irenaeus F M de CooDepartment of Neurology, Erasmus MC- Sophia, University Medical Center Rotterdam, The Netherlands.
Frans W VerheijenDepartment of Clinical Genetics, Erasmus MC University Medical Center, Rotterdam, The Netherlands.
Andreas KremerDepartment of Bioinformatics, Erasmus MC, University Medical Center Rotterdam, The Netherlands.ORCID http://orcid.org/0000-0003-1466-0600
Peter J van der SpekDepartment of Bioinformatics, Erasmus MC, University Medical Center Rotterdam, The Netherlands.
Daphne HeijsmanDepartment of Clinical Genetics, Erasmus MC University Medical Center, Rotterdam, The Netherlands.
Eric J WagnerDepartment of Biochemistry & Molecular Biology, University of Texas Medical Branch, Galveston TX, United States of America.
Maarten FornerodDepartment of Pediatric Oncology and Biochemistry, Erasmus MC, University Medical Center Rotterdam, The Netherlands.
Grazia M S ManciniDepartment of Clinical Genetics, Erasmus MC University Medical Center, Rotterdam, The Netherlands.
Erasmus MC · NLBaylor College of Medicine · USThe University of Texas Medical Branch at Galveston · USTemple University · US

Funding

Megalencephaly and segmental brain overgrowth in humansR01NS092772 · NINDS · SEATTLE CHILDREN'S HOSPITAL · PI MILLEN, KATHLEEN JOYCE · 2015 to 2019
$3.3M
NINDS NIH HHS R01 NS092772
6 · The paper itself

Abstract

Integrator is an RNA polymerase II (RNAPII)-associated complex that was recently identified to have a broad role in both RNA processing and transcription regulation. Importantly, its role in human development and disease is so far largely unexplored. Here, we provide evidence that biallelic Integrator Complex Subunit 1 (INTS1) and Subunit 8 (INTS8) gene mutations are associated with rare recessive human neurodevelopmental syndromes. Three unrelated individuals of Dutch ancestry showed the same homozygous truncating INTS1 mutation. Three siblings harboured compound heterozygous INTS8 mutations. Shared features by these six individuals are severe neurodevelopmental delay and a distinctive appearance. The INTS8 family in addition presented with neuronal migration defects (periventricular nodular heterotopia). We show that the first INTS8 mutation, a nine base-pair deletion, leads to a protein that disrupts INT complex stability, while the second missense mutation introduces an alternative splice site leading to an unstable messenger. Cells from patients with INTS8 mutations show increased levels of unprocessed UsnRNA, compatible with the INT function in the 3'-end maturation of UsnRNA, and display significant disruptions in gene expression and RNA processing. Finally, the introduction of the INTS8 deletion mutation in P19 cells using genome editing alters gene expression throughout the course of retinoic acid-induced neural differentiation. Altogether, our results confirm the essential role of Integrator to transcriptome integrity and point to the requirement of the Integrator complex in human brain development.

Indexed as

Gene DeletionMutation, MissenseAdultAlternative SplicingBrainCells, CulturedChildDevelopmental DisabilitiesFemaleFibroblastsHEK293 CellsHeLa CellsHeterozygoteHumansMaleMutationINTS8 protein, humanProtein SubunitsRNA, MessengerWnt1 ProteinWNT1 protein, human

Identifiers

PMID28542170
PMCPMC5466333
OpenAlexW2619399544

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.